Edwards Lifesciences' Sapien heart valve wins widened approval to include patients who are eligible for surgery

Edwards Lifesciences' heart valve wins widened approval
(Reuters) - Edwards Lifesciences Corp said U.S. health regulators widened the approved use of its Sapien artificial heart valve to include patients who are eligible for surgery but at high risk of serious surgical complications or death.

US HOT STOCKS: Edwards Lifesciences Active in Late Trading
Wall Street Journal
Edwards Lifesciences' third-quarter profit rose 34% as the medical-device company reported that sales of its transcatheter heart valves, while lower than expected, still jumped.



Sponsored Links: